Phase I Pharmacodynamic Study of CP-751,871 as Neoadjuv

Project: Research project

Project Details

Description

A Phase I Pharmacodynamic Study of CP-751,871 as Neoadjuvant Treatment For Early Breast Cancer (A4021012) [SPA NOTE: fka/aka Identification of Biomarkers to IGF-1R Activity in a Phase II Neoadjuvant Trial]
StatusFinished
Effective start/end date12/21/057/31/11

Funding

  • PFIZER, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.